ctrl K

Watchlist Price Alert

Antares Pharma Inc. (ATRS)

NASDAQ: ATRS · Real-Time Price · USD

5.59

0.01 (0.18%)

At close: Apr 24, 2025, 3:47 PM

Antares Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	65.91M	53.14M	23.2M	27.89M	26.56M	27.71M
Short-Term Investments	1.25M	n/a	22.52M	n/a	4.99M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	1.53M	1.31M	148K	148K	53.61K
Receivables	83.01M	50.36M	43.31M	29.42M	11.88M	9.07M
Inventory	11.54M	18.22M	16M	11.35M	9.28M	5.33M
Other Current Assets	n/a	4.88M	3.42M	2.65M	2.83M	3.15M
Total Current Assets	161.71M	126.59M	108.45M	71.31M	55.54M	45.26M
Property-Plant & Equipment	26.02M	28.64M	21.42M	14.89M	16.16M	17.87M
Goodwill & Intangibles	18.97M	8.79M	1.57M	1.93M	2.5M	3.14M
Total Long-Term Assets	78.03M	85.94M	24.3M	16.97M	18.8M	21.06M
Total Assets	257.5M	212.53M	132.75M	88.28M	74.34M	66.33M
Account Payables	17.06M	16.19M	12.9M	11.13M	5.96M	7.88M
Deferred Revenue	4.43M	3.94M	1.74M	1.02M	2.79M	6.15M
Short-Term Debt	4.21M	17.43M	1.25M	3.04M	n/a	n/a
Other Current Liabilities	33.23M	25.64M	16.52M	12M	6.98M	5.87M
Total Current Liabilities	58.93M	63.2M	32.41M	27.19M	15.73M	19.91M
Long-Term Debt	19.74M	24.67M	40.4M	22.08M	24.86M	n/a
Other Long-Term Liabilities	3.08M	5.54M	5.44M	n/a	n/a	n/a
Total Long-Term Liabilities	22.82M	30.21M	45.84M	22.08M	25.06M	1.2M
Total Liabilities	81.75M	93.42M	78.25M	49.28M	40.79M	21.11M
Total Debt	23.95M	42.1M	41.64M	25.13M	24.86M	n/a
Common Stock	1.7M	1.67M	1.65M	1.6M	1.57M	1.55M
Retained Earnings	-176.34M	-222.63M	-278.83M	-276.8M	-270.29M	-253.45M
Comprehensive Income	-685K	-683K	-702K	-703K	-700K	-714.27K
Shareholders Equity	175.76M	119.11M	54.5M	39M	33.55M	45.22M
Total Investments	1.25M	n/a	22.52M	n/a	4.99M	n/a